AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021
Jan 4, 2021
32464_dirs_2021-01-04_abf0cb8c-ee07-41d1-84f5-8969152543a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2020-12-30
Reporting Person: Velden Claus Vander (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-30 | Stock Option (Right to Buy) | $5.49 | A | 35000 | Acquired | 2030-12-30 | Common Stock (35000) | Direct |
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25